CardioFlow Transcatheter Mitral Valve Replacement System Pre-market Clinical Investigation
NCT: NCT07857343 · NOT_YET_RECRUITING
Brief Summary
This is a prospective, multi-center, single-arm study to assess the safety and effectiveness of Microport CardioFlow Transcatheter Mitral Valve Replacement system in the treatment of moderate to severe or severe degenerative mitral regurgitation and to provide the clinical evidence for product registration in China or other countries
Frequently Asked Questions
What is CardioFlow Transcatheter Mitral Valve Replacement System Pre-market Clinical Investigation?
CardioFlow Transcatheter Mitral Valve Replacement System Pre-market Clinical Investigation is a clinical trial registered under NCT07857343. Current status: NOT_YET_RECRUITING.
What is the status of NCT07857343?
The current status of NCT07857343 (CardioFlow Transcatheter Mitral Valve Replacement System Pre-market Clinical Investigation) is: NOT_YET_RECRUITING.
When did CardioFlow Transcatheter Mitral Valve Replacement System Pre-market Clinical Investigation start?
CardioFlow Transcatheter Mitral Valve Replacement System Pre-market Clinical Investigation started on 2026-12-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.